Category Medicine and Healthcare
Press Release
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform
Pre-clinical study to explore use of MODD1 pump as a delivery system for FDA-approved, short acting peptides, as a personalized alternative for people who discontinue long-acting GLP-1 formulations Read More
Press Release
Advanced Fertility Center of Texas Has Been Awarded on the Newsweek List of America’s Best Fertility Clinics 2024; Awarded #1 in Texas and #7 Nationwide
Advanced Fertility Center of Texas (AFCT) is proud to announce that it has been recognized on Newsweek and Statista Inc.'s list of America's Best Fertility Clinics 2024 Read More
Press Release
Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
New patents issued for core rare disease target indications for crofelemer Napo has approximately 200 patents issued and pending Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (MVID), an ultrarare CDD, in the US, EU, and Middle East/North Africa regions, with results expected in 2024 and 2025 Read More
Press Release
MMJ Shaking Up DEA Anti Marijuana Policy, Supreme Court Overturns Chevron Doctrine
Duane Boise, President of MMJ BioPharma Cultivation, stated, "I think most Americans want judges who don't mind telling the truth and don't mind saying we're wrong. Unlike the DEA's arrogant attitude of, if we make a mistake, we won't be called on it, however MMJ is doing exactly that. The most immature thing you can do is say, 'no, no, I didn't make a mistake.' The mature thing to do, that all adults learn to do in this country is to say, 'oops, that was a mistake. I'm going to fix it. I'm sorry.'" Read More
Press Release
GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences
GB Sciences' Licensing Deal with Endopure Life Sciences will also include Rights to Develop and Market GB Sciences' Cannabinoid-based Treatments for a Suite of Neurological Disorders Read More
Press Release
Supreme Court Ruling: MMJ Prepares To Up End DEA's "Kangaroo Court" And Anti Marijuana Research Policy
Duane Boise President of MMJ companies applauded the supreme court ruling saying "after years of DEA gross misconduct and blatant misinterpretation of marijuana research and development policy the Constitution still matters. Now the DEA will have to clean up their in-house kangaroo court system to allow a fair and impartial administrative law hearing". Read More
Press Release
